#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3608	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2155	485.2	0	.	n	.	0	A922G	SNP	922	922	A	1231	1231	G	515	G,A	249,200	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3608	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2155	485.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1759	1759	T	524	T,G	472,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3608	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2155	485.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1493	1493	C	499	C	439	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5818	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3874	450.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1823	1823	A	497	A	438	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5818	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3874	450.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2457	2457	C	521	C,T	465,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5818	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3874	450.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2531	2531	A	564	A,C	477,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5818	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3874	450.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3083	3083	C	561	C,T	477,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5818	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3874	450.2	0	HET	.	.	.	C206T	.	206	206	C	692	692	C	606	C,T	386,133	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	27	616	folP	852	852	99.88	folP.l15.c4.ctg.1	2027	91.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1186	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3755	94.8	1	SNP	p	S91F	0	.	.	271	273	TCC	781	783	TCC	116;117;117	T;C;C	104;103;103	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1186	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3755	94.8	1	SNP	p	D95G	0	.	.	283	285	GAC	793	795	GAC	116;116;116	G;A;C	107;104;103	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1186	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3755	94.8	1	SNP	p	D95N	0	.	.	283	285	GAC	793	795	GAC	116;116;116	G;A;C	107;104;103	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	498	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1621	92.1	0	.	p	.	0	A39T	NONSYN	115	117	GCC	622	624	ACC	137;138;138	A;C;C	124;123;123	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	498	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1621	92.1	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	820	822	CAC	135;133;133	C;A;C	115;115;114	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	498	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1621	92.1	0	.	p	.	0	E117K	NONSYN	349	351	GAA	856	858	AAA	143;143;143	A;A;A	125;125;123	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	498	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1621	92.1	1	SNP	p	G45D	0	.	.	133	135	GGC	640	642	GGC	136;135;134	G;G;C	124;121;122	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	352	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1292	81.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1100	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3256	101.2	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1611	1613	ATC	123;123;125	A;T;C	103;98;102	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1100	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3256	101.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1764	1766	GCA	116;117;118	G,A;C;A	101,1;99;99	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1100	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3256	101.2	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2247	2249	ATT	122;122;122	A,G;T;T	109,1;107;109	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1100	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3256	101.2	1	SNP	p	D86N	0	.	.	256	258	GAC	717	719	GAC	136;136;137	G,T;A;C	121,1;120;122	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1100	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3256	101.2	1	SNP	p	S87I	0	.	.	259	261	AGT	720	722	AGT	135;135;135	A;G;T	120;122;123	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1100	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3256	101.2	1	SNP	p	S87R	0	.	.	259	261	AGT	720	722	AGT	135;135;135	A;G;T	120;122;123	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1100	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3256	101.2	1	SNP	p	S87W	0	.	.	259	261	AGT	720	722	AGT	135;135;135	A;G;T	120;122;123	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	1100	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3256	101.2	1	SNP	p	S88P	0	.	.	262	264	TCC	723	725	TCC	137;137;138	T;C;C	124;123;123	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1082	parE	1986	1986	99.9	parE.l15.c4.ctg.1	3022	107.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1768	1770	GGC	149;148;148	G;G;C	134;131;131	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.002	penA.22.002	1	1	27	974	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2701	108.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1414	1416	GCA	132;132;133	G;C;A	117;119;118	penA.22.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	974	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2701	108.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1417	1419	ATC	134;135;136	A;T;C	117;119;120	penA.22.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	974	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2701	108.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1429	1431	GTG	139;139;139	G;T,C;G	122;119,1;118	penA.22.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	974	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2701	108.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1429	1431	GTG	139;139;139	G;T,C;G	122;119,1;118	penA.22.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	974	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2701	108.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1933	1935	ACC	136;138;138	A;C;C	123;121;124	penA.22.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	974	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2701	108.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1987	1989	GCG	138;137;139	G;C,A;G,T	117;105,1;112,1	penA.22.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	974	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2701	108.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1987	1989	GCG	138;137;139	G;C,A;G,T	117;105,1;112,1	penA.22.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	974	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2701	108.1	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2110	2112	GGT	143;144;144	G,C,A;G;T,C	120,2,1;123;118,1	penA.22.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	974	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2701	108.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2119	2121	GGC	146;146;145	G;G;C,G	123;126;124,1	penA.22.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	974	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2701	108.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2137	2139	CCG	144;144;144	C;C;G	117;127;123	penA.22.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1172	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3419	102.8	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1790	1792	CTG	111;111;111	C;T;G	93;93;93	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	690	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2075	99.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	713	713	C	124	C	108	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	728	porB1b	1047	1047	98.3	porB1b.l15.c30.ctg.1	1629	126.0	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	805	807	CAA	150;150;150	C;A;A	126;125;124	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	728	porB1b	1047	1047	98.3	porB1b.l15.c30.ctg.1	1629	126.0	0	.	p	.	0	E212G	NONSYN	634	636	GAA	1012	1014	GGT	115;115;116	G;G,C;T	104;103,1;104	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	728	porB1b	1047	1047	98.3	porB1b.l15.c30.ctg.1	1629	126.0	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1015	1017	GAT	117;118;118	G;A;T,C	105;105;104,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	728	porB1b	1047	1047	98.3	porB1b.l15.c30.ctg.1	1629	126.0	0	.	p	.	0	.	INDELS	643	644	GT	1022	1027	CTTATA	117;119;120;119;119;120	C;T;T;A;T;A	104;109;108;109;109;107	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	728	porB1b	1047	1047	98.3	porB1b.l15.c30.ctg.1	1629	126.0	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1039	1041	ATG	121;122;122	A;T;G	108;109;107	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	728	porB1b	1047	1047	98.3	porB1b.l15.c30.ctg.1	1629	126.0	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1156	1158	AAG	112;112;112	A;A;G	100;99;96	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	728	porB1b	1047	1047	98.3	porB1b.l15.c30.ctg.1	1629	126.0	1	SNP	p	G120K	0	.	.	358	360	GGC	736	738	GGC	159;159;158	G;G,T;C	140;138,1;139	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2462	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	5131	144.1	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2145	2147	CAT	145;145;147	C;A;T	126;121;128	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	372	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1370	81.5	1	SNP	p	V57M	0	.	.	169	171	GTG	717	719	GTG	146;147;147	G;T;G	128;129;129	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
